ANNE MILAM: Open Payments
NPI 1972639573 · PFLUGERVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,084 in 28 payments from 20 companies in 2025. Trend: 2023 $730 · 2024 $1,649 · 2025 $3,084
Food & beverage: $3,084
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $525 |
| Amgen Inc. | 2 | $280 |
| GENZYME CORPORATION | 2 | $242 |
| Abbott Laboratories | 1 | $167 |
| Neurocrine BioSciences, Inc. | 1 | $151 |
| Averitas Pharma Inc. | 2 | $150 |
| ABBVIE INC. | 2 | $144 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Shionogi Inc | 1 | $124 |
| Boston Scientific Corporation | 1 | $124 |
Products named: Livdelzi, PROCLAIM, INGREZZA, QUTENZA, MAVYRET, Yeztugo, KRYSTEXXA, REPATHA.
Industry payments across TX — which companies pay providers there.
